Agonists of Toll-like receptors 3, 4, 7, and 9 are candidates for use as adjuvants in an outer membrane vaccine against Neisseria meningitidis serogroup B

F. Fransen, C.J. Boog, J.P.M. van Putten, P. van der Ley

    Research output: Contribution to journalArticleAcademicpeer-review

    Original languageUndefined/Unknown
    Pages (from-to)5939-5946
    Number of pages8
    JournalInfection and Immunity
    Volume75
    Issue number12
    Publication statusPublished - 2007

    Cite this